Critical Role of FLRT1 Phosphorylation in the Interdependent Regulation of FLRT1 Function and FGF Receptor Signalling by Wheldon, Lee M. et al.
Critical Role of FLRT1 Phosphorylation in the
Interdependent Regulation of FLRT1 Function and FGF
Receptor Signalling
Lee M. Wheldon
1, Bryan P. Haines
2¤, Rajit Rajappa
3, Ivor Mason
3, Peter W. Rigby
2, John K. Heath
4*
1Molecular Bacteriology and Immunology Group (MBIG), Centre for Biomolecular Sciences, University of Nottingham, Nottingham, United Kingdom, 2Section of Gene
Function and Regulation, The Institute of Cancer Research, Chester Beatty Laboratories, London, United Kingdom, 3MRC Centre for Developmental Neurobiology, King’s
College London, London, United Kingdom, 4Cancer Research UK Growth Factor Group, School of Biosciences, University of Birmingham, Birmingham, United Kingdom
Abstract
Background: Fibronectin leucine rich transmembrane (FLRT) proteins have dual properties as regulators of cell adhesion
and potentiators of fibroblast growth factor (FGF) mediated signalling. The mechanism by which the latter is achieved is still
unknown and is the subject of this investigation.
Principal Findings: Here we show that FLRT1 is a target for tyrosine phosphorylation mediated by FGFR1 and implicate a
non-receptor Src family kinase (SFK). We identify the target tyrosine residues in the cytoplasmic domain of FLRT1 and show
that these are not direct substrates for Src kinase suggesting that the SFK may exert effects via potentiation of FGFR1 kinase
activity. We show that whilst FLRT1 expression results in a ligand-dependent elevation of MAP kinase activity, a mutant
version of FLRT1, defective as an FGFR1 kinase substrate (Y3F-FLRT1), has the property of eliciting ligand-independent
chronic activation of the MAP kinase pathway which is suppressed by pharmacological inhibition of either FGFR1 or Src
kinase. Functional investigation of FGFR1 and FLRT1 signalling in SH-SY5Y neuroblastoma cells reveals that FLRT1 alone acts
to induce a multi-polar phenotype whereas the combination of FLRT1 and FGFR activation, or expression of Y3F-FLRT1, acts
to induce neurite outgrowth via MAPK activation. Similar results were obtained in a dendrite outgrowth assay in primary
hippocampal neurons. We also show that FGFR1, FLRT1 and activated Src are co-localized and this complex is trafficked
toward the soma of the cell. The presence of Y3F-FLRT1 rather than FLRT1 resulted in prolonged localization of this complex
within the neuritic arbour.
Conclusions: This study shows that the phosphorylation state of FLRT1, which is itself FGFR1 dependent, may play a critical
role in the potentiation of FGFR1 signalling and may also depend on a SFK-dependent phosphorylation mechanism acting
via the FGFR. This is consistent with an ‘in vivo’ role for FLRT1 regulation of FGF signalling via SFKs. Furthermore, the
phosphorylation-dependent futile cycle mechanism controlling FGFR1 signalling is concurrently crucial for regulation of
FLRT1-mediated neurite outgrowth.
Citation: Wheldon LM, Haines BP, Rajappa R, Mason I, Rigby PW, et al. (2010) Critical Role of FLRT1 Phosphorylation in the Interdependent Regulation of FLRT1
Function and FGF Receptor Signalling. PLoS ONE 5(4): e10264. doi:10.1371/journal.pone.0010264
Editor: Cameron Neylon, University of Southampton, United Kingdom
Received June 15, 2009; Accepted March 25, 2010; Published April 22, 2010
Copyright:  2010 Wheldon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Cancer Research UK (www.cancer.org.uk), the Medical Research Council (www.mrc.ac.uk), the Wellcome Trust (www.
wellcome.ac.uk), and Fp6 Endotrack (www.endotrack.org). The funders had no role in study design, data collection and analysis, decision to publish,o r
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: j.k.heath@bham.ac.uk
¤ Current address: School of Molecular and Biomedical Science, The University of Adelaide, Adelaide, Australia
Introduction
Knowledge of the architecture of receptor tyrosine kinase
signalling pathways is rapidly expanding but much less is known
about the mechanisms that shape the spatial and temporal
dynamics of signal propagation. In particular, a number of agents
have been identified which attenuate or accelerate signalling
through downstream pathways [1] but their mechanisms of action
are frequently poorly understood. Here we focus on the
fibronectin leucine rich transmembrane proteins (FLRTs): a
subclass of the larger diverse leucine rich repeat (LRR) superfamily
[2] which act as multifunctional accelerators of fibroblast growth
factor receptor (FGFR) signalling. We, and others, have
demonstrated that: members of the FLRT family associate with
members of the FGFR family, accentuate FGF-mediated signal-
ling via the Ras/Raf/ERK pathway and play a role in cadherin-
dependent homotypic cell adhesion functions [3,4,5]. A key issue
in further understanding the function of FLRTs is to determine the
inter-relationships between these three cardinal properties.
Three members of the FLRT family (FLRT 1–3) have been
identified in higher vertebrates from functional screens and in
silico searches [6]. They exhibit canonical fibronectin and leucine
rich repeat motifs in the extracellular domain which mediate the
homotypic cell adhesion functions; a single transmembrane
domain and a short (,100 amino acid) cytoplasmic domain
devoid of overt signalling motifs. Each FLRT family member
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developing embryo [3,4,7]. FLRT1, the subject of this study, is
expressed in adult brain and kidney [6] and, in embryonic
development, is localized in the midbrain at the boundary with the
hindbrain and in the dorsal diencephelon adjacent to the
telencephalon, the eye, dorsal root and trigeminal ganglia and in
cells adjacent to the urogenital ridge [4]. This pattern overlaps
with regions of FGFR and FGF ligand expression suggestive of a
specific requirement for interaction of the FGF and FLRT axis in
these cell types. Indeed a potential role for FLRT action in
neuronal function has been proposed from studies of FLRT3
expression in neural regeneration models [8,9,10].
In this work we set out to further understand the functional
relationship between FGFR activation and FLRT function via an
initial analysis of FGFR-mediated phosphorylation of FLRT1. We
show that phosphorylation of FLRT1 in the cytoplasmic domain
modulates the ability of FLRT to activate the MAPK pathway and
induce neurite outgrowth. A non-phosphorylated form of FLRT1
acts as a chronic activator of FGFR1 signalling and both signalling
propagation and induction of neurite outgrowth require the
activity of a non-receptor Src family kinase.
Results
FLRT1 and FGFR1 are co-localized
We have previously documented an association between
FGFR1 and FLRT1 [4] and we were interested to learn the
cellular location(s) of this interaction. Cos-7 cells transiently co-
transfected with FGFR1 and FLRT1 demonstrated clear co-
localisation in punctate perinuclear intracellular vesicles
(Figure 1A, thick white arrows, upper and lower panels) and at
the cell surface membrane (Figure 1A, thin white arrows, lower
panels). This data shows that FGFR1 and FLRT1 localise to
similar multiple cellular compartments.
FGFR1 phosphorylates FLRT1
This pattern of co-localisation raised the possibility that FLRT1
could be a potential substrate for ligand-mediated FGFR1
phosphorylation which could, in principle, regulate FLRT
function. Co-transfection of FGFR1 and FLRT1 in 293T cells
results in robust ligand-independent tyrosine phosphorylation of
FLRT1 (Figure 1B), probably as a consequence of elevated
receptor population and ligand-independent FGFR1 activation,
showing that either FGFR1 itself or other downstream kinases can
utilise FLRT1 as a substrate.
Bioinformatic analysis of theoretical tyrosine phosphorylation
sites on the C-terminal region of FLRT1 (NetPhos 2.0 http://
www.cbs.dtu.dk/ services/NetPhos/) revealed 3 high probability
residues, Y600, Y633 and Y671. A panel of single, double and the
triple tyrosine substitution constructs was produced and examined
for expression and localisation in transfected 293T cells. In all
cases, protein was localized at both the plasma membrane and in
intracellular vesicular-like structures (data not shown) suggesting
that mutation of these cytoplasmic tyrosine residues to phenylal-
anine did not grossly perturb FLRT1 expression or intracellular
trafficking. Mutation of these tyrosine residues in FLRT1
decreased FGFR1-mediated FLRT1 tyrosine phosphorylation
compared to wild -type in all cases (Figure 2A). The single
tyrosine deletion constructs Y600F-FLRT1, Y633F-FLRT1,
Y671F-FLRT1 and the double mutant (Y600, 633F) Y2F-FLRT1
exhibit reduced, but not abolished, phosphorylation (,34%,
,32%, ,36% and ,42% inhibition, respectively) whereas the
triple mutant (Y3F-FLRT1) exhibited almost complete abolition of
tyrosine phosphorylation (Figure S1) equivalent to that observed
by pharmacological inhibition [11] of FGFR1 kinase with SU5402
(,88% and ,96% inhibition, respectively). These results establish
that Y600 , Y633 and Y671 are critical for FGFR1-mediated
phosphorylation of FLRT1, each site is phosphorylated and
FGFR1 activation is necessary and sufficient for FLRT1
phosphorylation. These findings also predict that Y3F-FLRT1 is
defective in a process (or processes) which require phosphorylation
of the 3 critical tyrosines.
We next sought to further characterise the kinase(s) responsible
for FGFR1 mediated phosphorylation of FLRT1 using a
pharmacological approach (Figure 2B). We were particularly
interested in the role of SFKs in view of our previous findings
[12,13] that Src activation is a consequence of FGFR1 activation
and Src activity is required for both receptor activation and
mediation of downstream signalling dynamics. We observed, as
before, almost complete inhibition of FLRT1 phosphorylation in
the presence of SU5402 (Figure 2B). We also observed significant
(83%) inhibition in the presence of the SFK inhibitor SU6656 [14]
(Figure S1) comparable to that observed in the Y3FFLRT1
deletion construct (,83% compared to ,88%). In parallel ERK
activation was significantly reduced in the presence of SU5402 or
SU6656 which reflected the effect on FLRT1 phosphorylation.
These data confirm that FLRT1 phosphorylation is FGFR-
dependent and implicate an SU6656-sensitive SFK in the
phosphorylation mechanism.
Since Src kinase acts both upstream and downstream of FGFR1
activation we next tested whether FLRT1 was a direct substrate for
Src. Constitutively active (KA-Src (Y527F) and kinase-dead (KD-
Src (K295M/Y527F)) Src were co-expressed with FLRT1 which
was tested for tyrosine phosphorylation (Figure 2C). This revealed a
very low degree of FLRT1 phosphorylation (even after 1006longer
than normal exposure times) which was suppressed by the FGFR1
kinase inhibitor SU5402, as was the ability of KA-Src to activate
ERK via phosphorylation. We conclude from these results that
FLRT1 is a poor substrate for Src kinase and that Src regulates
FLRT phosphorylation indirectly by virtue of the ability of KA-Src
to activate FGFR signalling in the absence of ligand [12].
Y3F-FLRT1 induces chronic ERK activation
Having established that FLRT1 is a target for FGFR1-mediated
phosphorylation we sought to examine the role of FLRT1
phosphorylation in the FGF-mediated ERK response [3] from
an endogenous FGFR population. 293T cells were transfected
with either FLRT1 or Y3F-FLRT1 triple mutant form and tested
for the dynamics of ERK activation in response to FGF
stimulation (Figure 2D). In accord with previous results, FLRT1
expression enhanced the FGF response both at early (1min) and
later time points (30 min). Much to our surprise, expression of
Y3F-FLRT1 resulted in chronic stimulation of the ERK pathway
both in the absence and presence of ligand. These results suggested
that the phosphorylation-defective form of FLRT1 emulated the
action of FGF in activating ERK signalling. Given that FLRT1
and FGFR1 coassociate we reasoned that the action of Y3F-
FLRT1 might arise from activation of FGFR1. 293T cells were
transfected with Y3F-FLRT1 and tested for ERK activation in the
presence of pharmacological inhibitors of FGFR kinase (SU5402)
and Src (SU6656). This revealed (Figure 2E) that the ability of
Y3F-FLRT1 to elicit ERK activation is completely dependent on
both FGFR and Src family kinase activity.
Thus the biochemical evidence reveals that FLRT1 is a target
for Src-dependent FGFR-mediated phosphorylation and abolition
of FLRT phosphorylation, by mutation of the substrate tyrosine
residues, resulted in chronic ligand-independent yet FGFR1de-
pendent ERK activation. This suggests a futile cycle relationship
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phosphorylated form of FLRT1 may activate FGFR1 via Src [12]
resulting in phosphorylation of FLRT1.
FLRT1 promotes neurite outgrowth in SH-SY5Y cells
Having established a functional interaction between FGFR1
and FLRT1 by biochemical approaches we next sought to study
the functional consequences in a physiological setting. Given the
evidence for regulated expression and function of FLRT3 in
neuronal cell types [8,9,10] and the known role of FGFR
signalling in neuronal function [15,16,17,18] we elected to study
the induction of neurite outgrowth in the SH-SY5Y cell line
[19,20]. Confluent cells were transfected with GFP (control) and
either FLRT1 or Y3F-FLRT1 alone or in conjunction with
Figure 1. Co-localization of FLRT1 and FGFR1. A) Immunofluorescent staining of Cos-7 cells co-transfected with plasmids encoding FGFR1 and
3’HA-tagged FLRT1 Cells were stained with anti-FGFR1 (green) and anti-HA (FLRT1 -red) Merged images show areas of co-localisation in yellow
Images (in section) were taken with a confocal microscope and are representative cells from 11 total fields of cells B) HEK 293T cells were co-
transfected with FGFR1 and either control vector (pcDNA31) or FLRT1 (FLRT-HA) with or without stimulation with FGF2 (20ng/ml) in the presence of
heparin (10mg/ml) for 30 min Anti-HA immunoprecipitation was performed on whole cell lysate which was subjected to western blot analysis with
anti-phosphotyrosine (IP: HA, Blot: pY) to identify phosphorylated FLRT1 (pFLRT1) Phosphorylated FGFR1 (pFGFR1) was co-immunoprecipitated with
FLRT1 The whole cell lysate (WCL) was probed for both FGFR1 (Blot: anti-FGFR1) and FLRT1 (Blot: anti-HA) expression Data is representative of at least
4 independent experiments.
doi:10.1371/journal.pone.0010264.g001
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analysed in a variation of the Scholl analysis [21] (Figure S2). Cells
were designated as polar, bipolar, pyramidal or multi-polar
depending upon cell shape and the number of primary processes.
Expression of either FLRT1 or Y3F-FLRT1 alone or co-
expression with FGFR1 results in a significantly higher proportion
of multi-polar cells and concomitant decreased numbers of other
neuron types (Figure 3A). This is consistent with the significantly
increased number of processes observed under these conditions
(Figure 3B, upper left panel).
Expression of FLRT1 alone results in significant increases in the
number of processes per cell (,68%) and the total dendritic length
(,31%) compared to GFP control (Figure 3B). There was no
significant difference in either the length of the longest process or
the maximum diameter of the cell (including processes – Scholl
diameter). This is consistent with the reported actions of FLRT
expression on neuronal function [8,10] possibly mediated via a cell
adhesion mechanism.
In contrast, both FLRT1/FGFR1 co-expression and Y3F-
FLRT1 expression results in comparable and significant increases
not only in the number of processes (,83% and ,66%,
respectively) and the total dendritic length (,267% and ,277%,
respectively), but also in the length of the longest process (,153%
and ,183%, respectively) and the Scholl diameter (,70% and
,81%, respectively) compared to GFP control (Figure 3B).
Comparison of FLRT1 and Y3F-FLRT1 showed a significant
increase in all parameters except the number of processes (,68%
and ,66%, respectively). Neurite outgrowth was completely
blocked in the presence of inhibitors of the MAPK pathway
(U0126), FGFR1 (SU5402) and SFKs (SU6656) (Figure S6).
There was a significant increase in the length of the longest
process and total dendritic length when Y3F-FLRT1 and FGFR1
were co-expressed (,55% and ,98%, respectively) compared to
GFP. Y3F-FLRT1/FGFR1 co-expression exhibited significant
reductions in all parameters when compared to either FLRT1/
FGFR1 or Y3F-FLRT1 expressing cells whilst in contrast there
was a significant decrease in process number and increase in
longest process when Y3F-FLRT1/FGFR1 were compared to
FLRT1 expressing cells (Figure 3B).
Dendritic architecture, the number and frequency of intersec-
tions and spines, is critical to the morphology and function of
neuronal cells. Using a variation on the Scholl analysis, the
number of spines and intersections was quantified as a function of
distance from the soma (per 10mm). Despite some significant
increases in dendritic complexity (Table S1), particularly for
FLRT1 (0–10mm), Y3F-FLRT1 (0–30mm) and FLRT1/FGFR1
(0–40mm) expressing cells, there was no change in the radial
profile of dendritic complexity with the peak remaining in the first
10mm and steadily declining with increased distance from the cell
body (Figure 3C). The rather surprising results we observed when
comparing FLRT1 only expression with Y3F-FLRT1/FGFR1 co-
expression suggest that up-regulation of FGFR1 can counteract
the effect of deregulating FLRT1 phosphorylation. Whilst
suggestive of a bipartite mechanism, this remains unclear and
further analysis will be required to resolve completely the functions
of FLRT that are FGFR-dependent/independent.
Together these data define two features of FLRT1 action in this
neuronal cell model. Dendritic architecture is regulated by FLRT1
alone whereas the length and complexity of dendrites is regulated
by the signalling functions of FLRT1 acting in concert with
FGFR1 activation.
FLRT1 promotes dendritic outgrowth in primary
hippocampal neurons
To determine effects of FLRT1 on a primary neuron
population, and confirm elevated activity of the Y3F-FLRT
mutant, cultures of developing rat hippocampal neurons were
transfected. These neurons have a single axon and a number of
dendrites emerging from the cell body or soma (primary dendrites)
and express both FGFR1 and FGFR2 (RR and IM submitted).
Following transfection, dendrites were identified with anti-MAP2b
and transfected cells with anti-HA antibodies and the number of
dendrites projecting from cell bodies were counted. Both FLRT1
and Y3F-FLRT1 produced a statistically significant increase in
numbers of primary dendrites compared to the control vector
expressing GFP. Moreover, the Y3F-FLRT1 variant generated
more primary dendrites than the normal FLRT1 protein
(Figure 4). These data were consistent with those obtained using
the SH-SY5Y neuroblastoma cell line (see above).
Co-localization of FLRT1 and Y3F-FLRT1 with FGFR1 and
Src family kinases
Having established the SH-SY5Y system as an appropriate
experimental platform to study FLRT function as similar effects
were observed in primary neurons, we next sought to define the
spatial localisation of FLRT1, activated FGFR and activated SFKs.
FLRT1 and Y3F-FLRT1 localize in a similar manner to the
plasma membrane, intracellular vesicles and punctate vesicular
staining along the length of processes and the terminal end buds of
processes in contact with other cells (Figure 5A and D and Figures
Figure 2. FLRT1 is not a SFK substrate but phosphorylation is FGFR-and SFK-dependent. A) HEK 293T cells were transfected with control
(pcDNA31) or FGFR1 and a panel of either full-length FLRT1-HA or tyrosine substitution contructs as indicated (see Materials & Methods) One sample
was pre-treated with FGFR kinase inhibitor (SU5402, 50mM, 1 hr) where indicated Cell lysates were immunoprecipitated with anti-HA and
subsequently blotted with anti-phosphotyrosine (IP: HA, Blot: pY) or anti-HA (IP: HA, Blot: HA) to examine phosphorylated FLRT1HA levels (pFLRT1) or
total immunoprecipitated FLRT1-HA levels (FLRT1), respectively Whole cell lysate (WCL) fractions were probed with anti-FGFR1 (Blot: FGFR) to control
for protein expression B) HEK 293T cells were transfected with pcDNA31, FGFR1 and FLRT1-HA as indicated Cells were pre-incubated (1hr) with
pharmacological inhibitors (SU5402, 50mM; SU6656, 20mM) Cell lysates were immunoprecipitated with anti-HA and subsequently blotted with anti-
phosphotyrosine (IP: HA, Blot: pY) for pFLRT1 and anti-HA (IP: HA, Blot: HA) for FLRT1 WCL fractions were probed with anti-FGFR1 (Blot: FGFR), anti-
phospho-ERK (Blot: pERK) or anti-ERK (Blot: ERK) Data in A) and B) are representative of $3 independent experiments Densitometric analysis (mean 6
sem, n=3) is the ratio of pFLRT1:FLRT1 and normalised to FLRT1 phosphorylation in the absence of inhibitor in both cases (**p,001, *p,005 non-
parametric one way ANOVA) C) HEK 293T cells were transfected with pcDNA31, FLRT1-HA alone or co-transfected with either a constitutively active
(KA) or kinase dead (KD) c-Src construct Cells were serum starved for 1hr and cell lysates immunoprecipitated with anti-HA and subsequently blotted
with anti-phosphotyrosine (IP: HA, Blot: pY) for pFLRT1 or anti-HA (IP: HA, Blot: HA) for FLRT1 WCL fractions were probed with anti-phospho-ERK (Blot:
pERK) or anti-ERK (Blot: ERK) Data are representative of 3 independent experiments D) HEK 293T cells were transfected with either pcDNA31 vector,
FLRT1-HA or Y3F-FLRT1-HA constructs Cells were co-stimulated with FGF2 (20ng/ml) and heparin (10mg/ml) for the indicated times Cell lysates were
blotted for anti-phospho-ERK (WCL IB: pERK), membranes were stripped and re-probed for anti-ERK (WCL IB: ERK) Densitometric analysis has been
adjusted for ERK loading and expressed as an arbitrary pERK:ERK ratio Data are representative of at least 4 independent experiments E) 293T cells
transfected with Y3F-FLRT1-HA were serum-starved in the absence or presence of pharmacological inhibitors of FGFR1 (SU5402, 50mM) and SFKs
(SU6656, 20mM) and whole cell lysates probed with antiphospho-ERK (IB: pERK), anti-ERK (IB: ERK) and anti-HA (Blot: HA) for Y3FFLRT1-HA.
doi:10.1371/journal.pone.0010264.g002
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localization in neurons [8].
In cells co-expressing FLRT1 and FGFR1, activated receptor
(as determined by phosphorylation of Y766; pFGFR1) localizes to
vesicular structures within the cell body and the central and
peripheral regions of processes; contrasting with FGFR1 only
expressing cells where pFGFR1 and activated Src remain
predominantly within the cell body (Figure S3). There was a
small amount of pFGFR1 and FLRT1 association confined to the
cell body membrane and the central regions of processes
(Figure 5A and Figure S4A).
Following FGF2 (5min) stimulation, pFGFR1 localization was
still observed in vesicular structures within the cell body and the
central and peripheral regions of processes and prominently co-
localized with both FLRT1 and pSFK (as determined by Y416
phosphorylation) in the peripheral regions of processes (Figure 5B
and see Figure S4B). Prolonged (30min) stimulation with FGF2
results in transport of the majority of pFGFR to intracellular
vesicular structures within the cell body where it co-localizes with
FLRT1 and pSFK (Figure 5C and Figure S4C).
Striking differences were observed when Y3F-FLRT1 was co-
expressed with FGFR1. pFGFR co-localizes with Y3F-FLRT1
and pSFK in both intracellular vesicles within the cell body and
the central and peripheral regions of processes. Very little pFGFR
co-localization with pSFK was observed independently of Y3F-
FLRT1, contrasting sharply with observations from FLRT1-
expressing cells. All of pFGFR, Y3F-FLRT1 and pSFK remained
co-localized in the central and peripheral regions of the processes,
and to a lesser degree within the cell body (Figure 5D–F and
Figure S4D–F). In this respect cells co-expressing Y3F-FLRT1
(Figure 5D) closely resemble cells co-expressing FLRT1 and
FGFR1 subjected to FGF stimulation (Figure 5C).
Collectively these data from a neuronal cell line confirm our
biochemical observations. Stimulation of cells by FGF ligand
results in activation of SFK(s) in peripheral locations and co-
localisation of pSFK, pFGFR and FLRT1 which traffic to the cell
body. This resembles our previous study of FGFR activation in
MEFs in which FGF stimulation results in peripheral co-activation
of FGFR and Src phosphorylation. In MEFs, activated Src
remains confined to the periphery whilst FGFR is trafficked to
perinuclear Rab5+ve vesicles [22]. In the FLRT1 expression
model employed here, activated FGFR1 is also trafficked from the
periphery to perinuclear locations but FLRT1 is never associated
with Rab5+ve vesicles Figure S5).
In the case of Y3F-FLRT1 the 3 molecules are ‘‘pre-localized’’
in intracellular perinuclear vesicles consistent with the ability of
Y3F-FLRT1 to activate FGFR1 signalling via a SFK-mediated
mechanism.
Discussion
In this report we have studied the functional interaction
between the FGFR and its binding partner, the signal accelerator,
FLRT1. We observe that tyrosine residues in the cytoplasmic
domain are targets for FGFR-mediated phosphorylation and
identify the residues involved. We show that mutation of the
residues has the unexpected consequence of yielding a form of
FLRT1 which has the property of eliciting chronic ligand-
independent yet FGFR-dependent MAP Kinase activation. Y3F-
FLRT1 is therefore a constitutive activator of FGFR signalling to
MAP Kinase. One apparent functional consequence of FGFR-
mediated phosphorylation may be to suppress the FGFR1
potentiation function of FLRT1. The FLRT/FGFR partnership
therefore resembles a futile cycle in which FLRT-mediated
activation of FGFR results in suppression of activation by feedback
phosphorylation. Futile cycle mechanisms are classically held to
exhibit super-sensitivity to input [23,24] which is what we observe
in the case of FGF. This mechanism therefore explains the ability
of wild type FLRT1 to markedly accelerate the early phase of
ligand-mediated signalling: this phase may represent the time
required for FLRT1 to switch phosphorylation states.
The second finding in this report is that the connection between
FLRT1 and FGFR1 may be moderated by a non-receptor tyrosine
kinase of the Src family. FLRT1 is not a direct substrate for Src
kinase but SFK activity is required for FGFR1-mediated FLRT1
phosphorylation. Conversely a SFK is implicated in the ability of
Y3F-FLRT1 to activate the FGFR. We have previously shown that
activated Src utilises FGFR as a substrate and pharmacological
inhibition of Src resulted in prolonged ERK activation due to
inhibition of signal decay [12]. This suggests the ability of
Y3FFLRT1 to activate FGFR signalling is indirect arising from
activation of Src kinase implying that a second consequence of
FLRT1 phosphorylation is suppression of its ability to activate Src.
Within this context, Src activation may be negatively regulated by
one or more of the three tyrosines in the cytoplasmic domain of
FLRT. We note that one target, Y600, is located adjacent to a
canonical PXXP SH3 domain binding motif and it has been
reportedinothersystemsthattyrosinephosphorylationeventsinthe
proximityofanSH3recognitionmotif suppresstheinteraction[25].
Although this is an attractive mechanism none of the single or
double mutant forms of FLRT1 exhibit MAPK activation
suggesting that the action of de-phosphorylated FLRT1 results
from the concerted action of all three phosphorylated residues.
Whilst this data is consistent with, and provides some evidence for,
the involvement of a SFK in the regulation of FGFR1 via FLRT1,
further studies are needed to investigate and clarify the role of SFKs
in the regulation and localisation of the FLRT1-FGFR1 interde-
pendent signalling mechanism.
We showed that the interaction between FGFR1 and FLRT1 has
functional consequences in both the SH-SY5Y neuronal cell model
and primary hippocampal neurons. Expression of FLRT1 alone
induces a multi-polar phenotype whereas expression of Y3F-FLRT1
or co-expression of FLRT1 and FGFR1 induced both a multi-polar
phenotype and elevated neurite outgrowth involving activation of
the MAP Kinase pathway. The FLRT1-mediated increase in
primary processes seen in the SH-SY5Y line was also seen in
elevated numbers of primary dendrites in hippocampal neuron
cultures and the increased signalling activity of the Y3-FLRT1
protein was reflected in a significant further increase in dendrite
production above that seen with FLRT1. Importantly, perturbation
ofFLRT1 phosphorylation resultedinderegulatedlocalisation ofthe
Figure 3. FLRT1 promotes neurite outgrowth in vitro. SH-SY5Y cells 48 hrs after transfection of either FLRT1-HA or Y3F-FLRT1-HA alone or co-
transfected with FGFR1, as indicated, were stained for FLRT1 (using anti-HA) prior tomorphological analysisA)Cells wereassigned a‘morphology’ basedon the
number of large diameter processes (.5mm in length) and cell shape as typified by the examples shown and B) several characteristic neuronal parameters
were determined, such as number of processes, length of the longest process, total dendritic length and maximum cell diameter (Scholl diameter) Data in A)
and B) was derived from N100 cells from at least 3 independent experiments C) the complexity of the dendritic arbour (Table S1) in a radial profile from the
soma, was measured in a variation of the Scholl analysis (Sholl, 1953; see Figure S2) Data are represented as mean 6 sem, n N 50 cells from at least 3
independent experiments Statistical significance in all instances used non-parametric Kruskal-Wallis and post hoc Dunns test (***p,0001, **p,001, *p,005)
Images were acquired on a Leica confocal microscope and Image J was used to process stacked confocal sections to allow data determination.
doi:10.1371/journal.pone.0010264.g003
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the neuritic arbour of SH-SY5Y cells. These findings suggest a dual
role for FLRT family proteins in neuronal function: one function is
mediated by the action of FLRT alone, presumably reflecting
consequences of its cell adhesion properties and the second arising
fromactivationofsignaltransductionpathwaysinvolving SFK(s)and
FGFR1. Although we appreciate the caveat of overexpression
systems and promiscuous signalling with regard to interpretation of
this study in terms of physiologically relevant FGFR1-FLRT1
interactions, it should be noted that FLRT3 was up-regulated in
response to both axotomisation and neuronal injury [8,9] and it has
been suggested that FLRT proteins play a role in neuronal
regeneration mechanisms when they are induced and FLRT
population at the membrane is elevated. Our study in primary
hippocampal neurons confirm our findings in SHSY5Y cells and
lend support to the hypothesized model of neuronal regeneration.
Figure 4. FLRT1 and Y3F-FLRT1 increase the number of primary dendrites in rat hippocampal neurons. (A–C) Representative confocal
microscopic images of the number of primary dendrites in hippocampal neurons transfected with IRES GFP control vector (A), FLRT1 (B) and Y3F-FLRT1
(C) The number of primary dendrites increased when the neurons were transfected with FLRT1 and Y3F-FLRT1 compared to the control (D) Graphical
representation of the average number of primary dendrites emerging from the soma under each condition There was a significant increase in primary
dendrites in boththeFLRT1-andY3F-FLRT1transfected neuronscomparedtothecontrol (P,00001, one-way analysis ofvariance andP=00008, Kruskal-
Wallis Test) Tukey’s Multiple Comparison Test also revealed that there was a significant difference between control and FLRT1 (P,001, **), control and
Y3F-FLRT1 (P,0001, ***) and FLRT1 and Y3F-FLRT1 (P,005, *) Data derived from several coverslips and two separate experiments.
doi:10.1371/journal.pone.0010264.g004
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PLoS ONE | www.plosone.org 8 April 2010 | Volume 5 | Issue 4 | e10264Figure 5. Differential trafficking and localization of activated FGFR1 by FLRT1 and Y3F-FLRT1. A–F) Representative confocal microscope
images of SH-SY5Y cells grown to confluency on coverslips and co-transfected with FGFR1, and either FLRT1-HA (A–C) or Y3F-FLRT1-HA (D–F) Cells
were fixed with either no stimulation, A) and D), or after exposure to FGF2 (20ng/ml) in the presence of heparin (10mg/ml) for 5 min, B) and E), or
30 min, C) and F) Cells were stained with anti-pY766FGFR1 (pFGFR1, red), anti-HA (FLRT1 and Y3F-FLRT1, green) and anti-pY416Src (pSrc, blue)
Merged images (and inset magnified images of cell body and neurites) demonstrated co-localization of FLRT1/FGFR1 (yellow), FLRT1/pSrc (cyan),
pFGFR1/pSrc (magenta) and FLRT1/pFGFR1/pSrc (white, white arrows) Images were acquired on a Leica confocal microscope and processed using
Image J and Adobe Photoshop 60 and represent at least 3 independent experimentsN Scale bar: 20mm.
doi:10.1371/journal.pone.0010264.g005
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PLoS ONE | www.plosone.org 9 April 2010 | Volume 5 | Issue 4 | e10264Analogous bipartite mechanisms of cell adhesion proteins on
sculpting neurite morphology have previously been reported for
Ig-domain cell adhesion molecules NCAM, N-cadherin [26],
neurofascin [27] as well as other leucine-rich repeat adhesion
molecules [28]. This dual role of FLRTs may explain the lack of
alteration of FGF target gene expression in early mouse embryos
homozygous for a mutation in the FLRT3 gene [29] with the
phenotypes seen in these embryos due to FLRT function
independent of FGFR signalling. The dual action of adhesion
molecules and FGFR signalling may represent key mechanisms for
refining the spatial and temporal dynamics of FGFR signalling
during neuronal development and function.
Materials and Methods
Cell culture and transfection
HEK 293T cells were cultured at 37uC, 5% CO 2 in Dulbecco’s
modified Eagle medium (DMEM, Invitrogen) supplemented with
2mM L-glutamine (Invitrogen), 0.1 mg/ml streptomycin, 0.2 U/
ml penicillin (Sigma), 1mM sodium pyruvate (Sigma), 10% (v/v)
fetal calf serum (FCS -Labtech International). SH-SY5Y cells were
cultured in RPMI 1640 (Invitrogen) supplemented with 2mM L-
glutamine (Invitrogen), nonessential amino acids (GIBCO),
0.1 mg/ml streptomycin, 0.2 U/ml penicillin (Sigma) and 10%
(v/v) FCS. For FGF2 stimulation, cells were serum starved by
replacing media with Krebs HEPES Buffer (KHB), and incubated
at 37uC (1 hour) prior to the addition of either 20ng/ml
recombinant human FGF2 (in the presence of 10mg/ml heparin,
stimulated) or vehicle (KHB, non-stimulated) for the indicated
times.
Using the C-terminal HA-tagged FLRT1 cDNA [4] as a
template, cDNAs of FLRT1 with Y600 (Y600F-FLRT1) or Y633
(Y633F-FLRT1) and both tyrosines (Y2F-FLRT1) mutated to
phenylalanine were constructed by PCR with the open reading
frame reconstructed using a unique Xba1 site present between
these residues. FLRT1 cDNAs with either the Y671 (Y671F-
FLRT1) or three tyrosines, Y600, Y633 and Y671 (Y3F-FLRT1),
mutated were constructed by ‘Quickchange’ mutagenesis (Strata-
gene) on wild-type C-terminal HA tagged FLRT1 and Y2F-
FLRT1, respectively. Expression constructs for mammalian cells
were in pCDNA3.1 (Invitrogen). Plasmids encoding human
FGFR1 [30], HA-tagged FLRT1 constructs or Src constructs
(M.Frame, Beatson Institute, Glasgow), were transiently transfect-
ed into HEK293T cells by the DNA/CaPO4 precipitation
method, incubated on the cells overnight and cells washed the
following morning with Ultracho (Cambrex) and the media
replaced with 2ml of Ultracho. Recombinant proteins were
expressed for 48 hrs.
Cell lysis, immunoprecipitation (IP) and western blot
analysis (IB)
HEK 293T cells were lysed with RIPA buffer (supplemented
with 1mM Na3VO4, 50mM NaF, 25mM b-glycerophosphate and
1 tablet of complete protease inhibitor cocktail (Roche) per 10ml of
buffer, pH 8.0). Aliquots of whole cell lysate were subjected to
SDS-PAGE and the remainder subjected to immunoprecipitation
by the addition of 2ml of monoclonal anti-HA (6E2-Cell
Signalling) and incubation at 4oC for 1hr. Immuno-captured
complexes were isolated by the addition of 20ml of protein-
Asepharose fast flow (Amersham Biosciences, Inc., UK) and
incubated for 30min at 4oC. Samples were washed (36) with Tris
Buffered Saline-Tween (TBS-T: 10mM Tris/HCl, pH 7.4, 75mM
NaCl, 0.05% Tween-20 (v/v)) and then washed (26) with TE
buffer before bound proteins were eluted by boiling with SDS
sample buffer containing 200mM DTT, pH 6.8.
Protein samples were run on 4–20% gradient SDS PAGE
(Lonza) at 125V and calibrated with SeeBlue Plus2 pre-stained
markers (10Nl, Invitrogen). Gels were transferred to nitrocellulose
membrane (Protran BA85, Schleicher and Schuell) at 200mA/gel
for 1 hour on a Biometra Semi-dry transfer system. Membranes
were blocked in TBS-T containing 5% bovine serum albumin
(BSA, w/v). Primary antibodies (in TBS-T/5% BSA) were
incubated with the membrane at either 4oC overnight or 1 hr at
room temperature. Membranes were washed (3615 min) in TBS-
T and subsequently probed with conjugated secondary antibody
(in TBS-T/5% BSA) for 45 min at room temperature. The
membrane was washed (5610 min) with TBS-T, before mem-
branes were exposed to EZ-ECL (Geneflow) for visualization of
immunoreactive proteins. Antibodies included anti-FGFR1 (C15,
Santa Cruz), anti-HA (6E2, Cell Signalling), anti-phosphotyrosine
cocktail of 4G10 (Upstate) and pY20 (MP Biomedicals Ltd), anti-
ERK (K23-Santa Cruz) and anti-phosphoERK (E4-Santa Cruz).
Immunofluorescence
For immunofluorescence studies, Cos-7 or SH-SY5Y cells were
grown on coverslips and transfected (Fugene 6 (Roche) or
Genejuice (Invitrogen), respectively) as per the manufacturer’s
instructions. 48 hours post transfection Cos-7 cells were fixed and
permeabilised in methanol for 2 min at -20oC and re-hydrated in
PBS for 15 min whilst SH-SY5Y cells were fixed with 4% PFA
and permeabilised with methanol (5 min at 220uC). Following
1hr incubation in PBS/4% BSA to reduce non-specific binding,
coverslips were incubated with primary antibody(s): anti-HA
(HA.11, 1:500, Covance); anti-HA (6E2, 1:200); anti-FGFR1
(C15, 1:50, Santa Cruz); anti-pY766 FGFR1 (Tyr766m, 1:100,
Santa Cruz); anti-pY416 Src (2101S, 1:100, Cell Signalling); in
PBS-T/4% BSA for 1hr. Coverslips were washed 3 times in PBS
and incubated with secondary antibody(s): anti-mouse Alexa 555
antibody (1:1000); anti-rabbit Alexa 488 antibody (1:1000); anti-
goat Alexa 594 (1:200); anti-rabbit Alexa 647 (1:250); anti-mouse
FITC (1:400); anti-rabbit FITC (1:200); anti-mouse Texas Red
(1:200) (all from Molecular Probes), in PBS-T/4% BSA for 1hr
and washed 3 times in PBS containing 0.1% Tween-20, once in
dH2O. Coverslips were mounted using Vectastain (Cos-7)/
Mowiol (SH-SY5Y) mounting media and images obtained as
sections by confocal microscope (Leica).
Transfection of cultured hippocampal neurons
Primary hippocampal cultures were prepared from embryonic
day 18 Sprague-Dawley rats. Hippocampi were dissociated with
trypsin (5mg/ml for 15 min at 37oC; Worthington), triturated and
plated onto coverslips coated with poly-D-lysine (50 mg/ml) and
laminin (20 mg/ml) at a density of 90,000 neurons per coverslip.
Neurons were incubated at 37oC in 5% CO2 in Neurobasal
medium supplemented with B27, glutamax and penicillin/
streptomycin (all Gibco). After 5 days in culture, neurons were
transfected with 1 Ng/ml plasmid DNA using Lipofectamine 2000
(Invitrogen). They were cultured for a further 9 days, fixed in 4%
(w/v) paraformaldehyde phosphate-buffered saline (PBS) and
permeablized with 0.25% (v/v) Triton X-100 in PBS.
After blocking with 10% (w/v) bovine serum albumin (BSA) in
PBS, coverslips were incubated for 2 hours at room temperature
with one or more of the following antibodies in 3% BSA: mouse
anti-HA (1:400; Abcam) and rabbit anti-MAP2b (1:500; Abcam).
After washing, cells were incubated for 1 hour at room
temperature in 3% BSA containing the appropriate secondary
antibodies (conjugated to Alexa 568 or Alexa 633; Invitrogen).
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confocal microscope. Statistical analyses were performed with a
Kruskal-Wallis Test for one-way variance and with Tukey’s
Multiple Comparison Test.
Supporting Information
Figure S1 FGF2-dependent phosphorylation of FLRT1. HEK
293T cells were transfected with the indicated constructs and pre-
incubated with pharmacological inhibitors where indicated (1hr).
Following 20 min stimulation with FGF2 (20ng/ml) and heparin
(10mg/ml) cell lysates were A) immunoprecipitated with anti-HA (IP:
HA) and subsequently blotted with anti-phosphotyrosine (Blot: pY) or
anti-HA (Blot: HA). Whole cell lysate fractions (WCL) were probed
with anti-FGFR1 (Blot: FGFR1) to control for protein expression B)
Immunoprecipitated with anti-HA (IP:HA) and subsequentlyblotted
with anti-phosphotyrosine (Blot: pY), anti-HA (Blot: HA) or anti-
FGFR1 (Blot: Flg). Whole cell lysate fractions (WCL) were probed
with anti-phosphoERK (Blot: pERK) or anti-ERK (Blot: ERK). Data
in A) and B) are representative of 3 independent experiments.
Densitometric analysis (mean +/2 s e m ,n = 3 )a n da d j u s t e df o r
FLRT1 expression and normalised to FLRT1 phosphorylation when
wild type FLRT1 is co-expressed with FGFR1 (**p,0.01, *p,0.05
non-parametricone way ANOVA).C) 293T cellswereco-transfected
with either a constitutively active (KA) or kinase dead (KD) c-Src.
Cells were stimulated with FGF2 and heparin (as above). Cell lysates
were immunoprecipitated with anti-HA (IP: HA) and subsequently
probed with anti-phosphotyrosine (Blot: pY) or anti-HA (Blot: HA).
Whole cell lysates (WCL) were probed for anti-phosphoERK (Blot:
pERK) and anti-ERK (Blot: ERK). Data are representative of two
independent experiments.
Found at: doi:10.1371/journal.pone.0010264.s001 (0.97 MB TIF)
Figure S2 Variation on the Scholl analysis. Neuronal morphol-
ogy was assessed using Image J to determine the following
parameters. The number of processes .5mm in length (*) were
counted; the length ofprocesseswas determinedbyfreehand tracing
(green line); the total dendritic length is the sum of all measured
processes; the maximum diameter (Scholl diameter - solid red line)
was measured; and dendritic complexity assessed by counting the
number of spines and intersections along a process, every 10mm
from the cell soma (red dotted circles). Scale bar=10mm.
Found at: doi:10.1371/journal.pone.0010264.s002 (5.70 MB TIF)
Figure S3 Transfected FGFR1 associates with pSrc but remains
predominantly within the cell body. Confocal analysis of SH-SY5Y
cells grown to confluence and transfected with FGFR1. Following
48 hrs of expression, cells were fixed following either no stimulation or
after exposure to FGF2 (20ng/ml) and heparin (10mg/ml) for 5 and
30 min. Cells were stained with anti-pY766FGFR1 (pFGFR, red) and
anti-pY416Src (pSrc, blue) and merged to show co-localization of
pFGFR/pSrc (magenta). Images were acquired on a Leica confocal
microscope and processed using Image J and Adobe Photoshop 6.0
and represent 2 independent experiments. Scale bar: 20mm.
Found at: doi:10.1371/journal.pone.0010264.s003 (2.25 MB TIF)
Figure S4 Localization of FLRT1, pFGFR1 and pSrc. Confocal
images of SH-SY5Y cells transfected with either FLRT-HA (A–C)
or Y3F-FLRT1-HA (D–F). Following 48 hrs of expression, cells
were fixed following either no treatment (A and D) or following
FGF2 stimulation (B, C, E, F). Cells were stained for anti-HA
(Y3F-FLRT1, green), anti-pY766FGFR1 (pFGFR, red) or anti-
pY416Src (pSrc, blue). Merged images demonstrate co-localiza-
tion of Y3F-FLRT1/pFGFR (yellow), Y3F-FLRT1/pSrc (cyan)
and pFGFR/pSrc (magenta). Images were acquired on a Leica
confocal microscope and processed with Image J and Adobe
Photoshop 6.0 and represent three independent experiments.
Scale bar: 10mm.
Found at: doi:10.1371/journal.pone.0010264.s004 (3.08 MB TIF)
Figure S5 Neither FLRT1 nor Y3F-FLRT1 co-localize with
Rab5. Confocal sections of SH-SY5Y cells grown on coverslips
and transfected with A) FLRT1-HA or B) Y3F-FLRT1-HA. Cells
were fixed following either no stimulation or after exposure to
FGF2 (20ng/ml) and heparin (10mg/ml) for either 5 or 30 min.
Cells were stained with anti-HA (FLRT1 and Y3F-FLRT1, red)
and anti-Rab5 (S19, 1:300, Santa Cruz, green). Merged images
demonstrated no co-localization of FLRT1/Rab5 or Y3F-
FLRT1/Rab5. Images were acquired on a Leica confocal
microscope and processed using Image J and Adobe Photoshop
6.0 and represent 3 independent experiments. Scale bar: 20mm.
Found at: doi:10.1371/journal.pone.0010264.s005 (5.74 MB TIF)
Figure S6 Pharmacological Inhibition of neurite outgrowth in
the SH-SY5Y cells. SH-SY5Y cells were transfected with GFP
(control), FLRT1-HA or Y3F-FLRT1-HA and simultaneously
treated with inhibitors (U0126, MEK inhibitor; SU5402, FGFR
inhibitor; SU6656, SFK inhibitor; SB203580, p38 MAPK
inhibitor). After 48 hours of treatment, cells were analysed by
direct confocal microscopy (in the case of GFP-expressing cells) or
stained for anti-HA (FLRT1 and Y3F-FLRT1, green, middle and
right hand panels respectively). Inhibition of the p38 MAPK had
no visible effect on either cell morphology or the ability of either
FLRT1 or Y3F-FLRT1 to promote neurite outgrowth. Inhibition
of either MEK/ERK (U0126) or SFK (SU6656) signalling resulted
in a complete loss of neurite outgrowth from the cells consistent
with evidence in the literature that has implicated SFKs and ERK
as critical processes for neurite extension. In line with our model of
FLRT1-mediated modulation of FGFR1 signalling, inhibition of
the receptor by SU5402 prevented neurite outgrowth in both the
control and FLRT1 expressing cells. In contrast, neurite
outgrowth in cells expressing Y3F-FLRT1, which is receptor-
independent for activation of ERK, was unaffected by SU5402
treatment. Images were acquired on a Leica confocal microscope,
Image J and Adobe Photoshop 6.0 were used to process captured
data.
Found at: doi:10.1371/journal.pone.0010264.s006 (2.95 MB TIF)
Table S1 Statistical summary of SH-SY5Y dendritic architec-
ture analysis by non-parametric Kruskal-Wallis and post hoc
Dunns test.
Found at: doi:10.1371/journal.pone.0010264.s007 (0.05 MB
DOC)
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